Court of Justice of European Union Overrules Neurim Case Law and Excludes Right to SPC for New Medicinal Product
- 17/07/2020
- Articles
Attached is a note discussing the judgment of the Court of Justice of the European Union in Santen which excludes the right to an SPC for new medical uses of a previously authorised medicinal product. The judgment has far reaching consequences in denying SPC’s to specific repurposed medicines. It is also remarkable in that it expressly overrules and reverses the Neurim case law.
